Drug counters sleepiness from antidepressants

Key points
- Some people taking the newer class of antidepressants experience excessive sleepiness and fatigue, but this can be prevented with a drug that's used to treat narcolepsy, according to a new report.
- Antidepressants like Prozac or Zoloft are classified as selective serotonin reuptake inhibitors, or SSRIs.
- Schwartz and colleagues at the New York Upstate Medical University in Syracuse, New York, wondered if Provigil (modafinil) - a drug approved for treating excessive sleepiness in truck drivers and shift workers, as well as patients with narcolepsy - might help patients taking SSRIs.
- To investigate, the team enrolled 20 adults in a 3-week study to determine the effect of modafinil, given once daily, on sedation related to serotonergic drugs.
Some people taking the newer class of antidepressants experience excessive sleepiness and fatigue, but this can be prevented with a drug that's used to treat narcolepsy, according to a new report.
Antidepressants like Prozac or Zoloft are classified as selective serotonin reuptake inhibitors, or SSRIs. Even though they have less of a sedative effect than previous types of antidepressants, some people are still affected.
Dr. Thomas L. Schwartz and colleagues at the New York Upstate Medical University in Syracuse, New York, wondered if Provigil (modafinil) - a drug approved for treating excessive sleepiness in truck drivers and shift workers, as well as patients with narcolepsy - might help patients taking SSRIs.
To investigate, the team enrolled 20 adults in a 3-week study to determine the effect of modafinil, given once daily, on sedation related to serotonergic drugs. All the participants had major depressive disorder, but all reported that sedation, fatigue, and low energy had developed only after they began to take SSRIs.
In the 16 patients who completed the study, the addition of modafinil "significantly improved overall depressive symptoms," the researchers report in the Journal of Clinical Psychiatry. Also, modafinil therapy was associated with improved subjective impressions of wakefulness and reduced fatigue.
By their final study visit, the study participants showed improvements in their overall health status and health-related quality of life.
"Generalization of these findings is limited by the open-label nature of (the study), exclusion of a control group, and selective entry criteria for study participants," Schwartz's team acknowledges. Still, they conclude, "These positive findings ... warrant further systematic study."
SOURCE: Journal of Clinical Psychiatry, September 2004.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsPrior drug use is the greatest predictor of ecstasy use US high school seniors
Ecstasy, also known by its chemical abbreviation MDMA, is an illicit drug that is commonly taken at nightclubs and dance parties. Ecstasy’s street names include: “Molly” (U.S.), “Mandy” (U.K.), “E,” and “X.” Although…
26 June 2014
NewsIn utero exposure to antidepressants may influence autism risk
A new study from researchers at Drexel University adds evidence that using common antidepressant medications during pregnancy may contribute to a higher risk of autism spectrum disorders (ASD) in children, although this…
4 June 2014
NewsBUSM researchers find anti-seizure drug may reduce alcohol consumption
Researchers from Boston University School of Medicine (BUSM) have discovered that the anti-seizure drug ezogabine, reduced alcohol consumption in an experimental model. The findings, reported in the American Journal of…





